4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-010677
CEO and CFO bought 6,000 shares at $16.09 ($96,540)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-04-21 | Purchase | +6,000 | $16.09 | $96,540 | 1,216,929 | D |
| Open-market purchases · 6,000 sh · avg $16.09 · $96,540 | |||||||
Loading xslF345X03/ownership.xml…